医薬品製造装置市場 – 2029年までの世界予測

Report Overview

The global pharmaceutical manufacturing equipment market size is projected to grow from USD 19.41 billion in 2024 to USD 26.94 billion in 2029, recording a CAGR of 6.8% during the forecast period. Rising demand for generic drugs is driving the growth of the pharmaceutical manufacturing equipment market. Whereas the demand for refurbished equipments is restraining the growth of the pharmaceutical manufacturing equipment market.

世界の医薬品製造装置市場規模は、2024年の194億1,000万米ドルから2029年には269億4,000万米ドルに成長すると予測されており、予測期間中に6.8%のCAGRを記録します。ジェネリック医薬品の需要の高まりが医薬品製造装置市場の成長を牽引しています。一方、再生機器の需要は医薬品製造機器市場の成長を抑制しています。

“Packaging machines segment is expected to witness highest CAGR during the forecasted period in pharmaceutical manufacturing equipment market.”

The packaging machines segment is expected to have the highest CAGR in the pharmaceutical manufacturing equipment market due to a few critical factors. Innovative drug delivery formats such as pre-filled syringes, single-dose vials, and blister packs are gaining much importance in the pharmaceutical industry, which requires advanced and sophisticated packaging solutions. In addition, adoption of sophisticated packaging technologies, such as serialization and tamper-evident solutions, is stringent regulatory requirements for drug safety and traceability. It is also due to the growing trend of patient-centric healthcare, where packaging is playing an important role in enhancing user convenience and compliance. The growth in biologics, personalized medicines, and vaccines also requires highly precise and sterile packaging environments, thereby further driving demand for advanced packaging machines.

“Liquid segment is likely to witness highest CAGR in pharmaceutical manufacturing equipment market during forecasted period .”

The liquid segment is witnessing the CAGR due to regulatory emphasis on pediatric formulations. Regulatory bodies such as the US Food and Drug Administration (FDA) have stressed the need for age-appropriate liquid medications to address the challenges children face with swallowing solid forms like tablets and capsules. This push ensures better compliance, safety, and efficacy in pediatric treatments, significantly driving demand for liquid dosage forms. Additionally, liquid medications allow precise dosing, making them ideal for children and other patients requiring tailored administration. The growing focus on pediatric health has led pharmaceutical companies to innovate in liquid formulations, opening new market opportunities.

“Europe is expected to hold the second largest market share of the pharmaceutical manufacturing equipment market during forecasted period”.

The region is marked by a very competitive landscape, dominated by both large pharmaceutical companies and SMEs, thus facilitating innovation and diversification in terms of products. A tremendous investment in R&D for new manufacturing technologies supports the region’s dominance in this market. Biopharmaceuticals form a great shift in the industry and have transformed it across Europe; Germany has emerged to be the largest producer of EU-approved biopharmaceutical substances. This growth is matched by increasing revenues from biologics, which further strengthens the the pharmaceutical manufacturing equipment market in Europe.

Breakdown of primaries

The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:

• By Company Type – Tier 1 – 40%, Tier 2 – 35%, Tier 3 – 25%
• By Designation— C-level Executives – 45%, Directors – 35%, Others – 20%
• By Region—North America – 30%, Europe – 25%, Asia Pacific – 40%, RoW – 5%

The pharmaceutical manufacturing equipment market is dominated by a few globally established players such as GEA Group Aktiengesellschaft (Germany), I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P.A. (Italy), Syntegon Technology GmbH (Germany), Romaco Group (Germany), ACG (India), Körber AG (Germany), Thermo Fisher Scientific Inc. (US), Marchesini Group (Italy), MG2 s.r.l (Italy), Glatt GmbH (Germany). The study includes an in-depth competitive analysis of these key players in the pharmaceutical manufacturing equipment market, with their company profiles, recent developments, and key market strategies.

Research Coverage:

The report segments the pharmaceutical manufacturing equipment and forecasts its size by equipment type, end product type, and region. The report also discusses the drivers, restraints, opportunities, and challenges pertaining to the market. It gives a detailed view of the market across four main regions—North America, Europe, Asia Pacific, and RoW. Supply chain analysis has been included in the report, along with the key players and their competitive analysis in the pharmaceutical manufacturing equipment ecosystem.

Key Benefits to Buy the Report:

• Analysis of key drivers (Rising demand for pharmaceuticals, technological advancements in equipment and growing implementation & adoption of regulatory guidelines). Restraint (Demand for refurbished equipment), Opportunity (Growth in personalized medicines), Challenges (Rising costs and expenditures related to usage of pharmaceutical manufacturing equipment).
• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the pharmaceutical manufacturing equipment market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the pharmaceutical manufacturing equipment market across varied regions
• Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the pharmaceutical manufacturing equipment market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players GEA Group Aktiengesellschaft (Germany), I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P.A. (Italy), Syntegon Technology GmbH (Germany), Romaco Group (Germany), ACG (India) among others in the pharmaceutical manufacturing equipment market.

Table of Contents

1               INTRODUCTION              26

1.1           STUDY OBJECTIVES       26

1.2           MARKET DEFINITION   27

1.3           STUDY SCOPE   27

1.3.1        MARKETS COVERED AND REGIONAL SCOPE      27

1.3.2        INCLUSIONS AND EXCLUSIONS 28

1.3.3        YEARS CONSIDERED      28

1.4           CURRENCY CONSIDERED            28

1.5           UNIT CONSIDERED        29

1.6           STAKEHOLDERS               29

1.7           LIMITATIONS    29

1.8           SUMMARY OF CHANGES               29

2               RESEARCH METHODOLOGY       30

2.1           RESEARCH DATA              30

2.1.1        SECONDARY DATA          31

2.1.1.1    List of key secondary sources              31

2.1.1.2    Key data from secondary sources       31

2.1.2        PRIMARY DATA 32

2.1.2.1    List of primary interview participants               32

2.1.2.2    Breakdown of primaries      32

2.1.2.3    Key data from primary sources           33

2.1.2.4    Key industry insights           33

2.1.3        SECONDARY AND PRIMARY RESEARCH 34

2.2           MARKET SIZE ESTIMATION METHODOLOGY     34

2.2.1        BOTTOM-UP APPROACH              36

2.2.1.1    Approach to arrive at market size through bottom-up analysis (demand side)       36

2.2.2        TOP-DOWN APPROACH                37

2.2.2.1    Approach to arrive at market size through top-down analysis (supply side)         37

2.3           MARKET BREAKDOWN AND DATA TRIANGULATION                 38

2.4           RESEARCH ASSUMPTIONS           39

2.5           RESEARCH LIMITATIONS             39

2.6           RISK ANALYSIS  40

3               EXECUTIVE SUMMARY  41

4               PREMIUM INSIGHTS       44

4.1           ATTRACTIVE GROWTH OPPORTUNITIES FOR PLAYERS IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET                 44

4.2           PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE 45

4.3           PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE          45

4.4           PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY 46

5               MARKET OVERVIEW       47

5.1           INTRODUCTION              47

5.2           MARKET DYNAMICS       47

5.2.1        DRIVERS               48

5.2.1.1    Growing rate of chronic diseases       48

5.2.1.2    Adoption of modular manufacturing setups    48

5.2.1.3    Increasing implementation and adoption of regulatory guidelines                 48

5.2.2        RESTRAINTS      50

5.2.2.1    Rising adoption of refurbished equipment       50

5.2.3        OPPORTUNITIES              50

5.2.3.1    Growing demand for personalized medicines  50

5.2.3.2    Rising demand for biopharmaceuticals             51

5.2.4        CHALLENGES    51

5.2.4.1    Adherence to multiple regulations and standards           51

5.3           TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS            52

5.4           PRICING ANALYSIS          53

5.4.1        INDICATIVE PRICING OF KEY PLAYERS, BY EQUIPMENT TYPE, 2023           53

5.4.2        AVERAGE SELLING PRICE TREND OF PHARMACEUTICAL PACKAGING MACHINES, 2019–2023  54

5.4.3        AVERAGE SELLING PRICE TREND, BY REGION, 2019–2023                 55

5.5           VALUE CHAIN ANALYSIS               56

5.6           ECOSYSTEM ANALYSIS  58

5.7           IMPACT OF AI/GENERATIVE AI ON PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET             59

5.8           TECHNOLOGY ANALYSIS             60

5.8.1        KEY TECHNOLOGIES     60

5.8.1.1    Digital twin            60

5.8.1.2    Automation and robotics     60

5.8.1.3    IoT          61

5.8.2        COMPLEMENTARY TECHNOLOGIES       61

5.8.2.1    3D printing            61

5.8.3        ADJACENT TECHNOLOGIES       61

5.8.3.1    CAD and CAM     61

5.9           PATENT ANALYSIS          62

5.10         TRADE ANALYSIS             64

5.10.1      IMPORT DATA (HS CODE 842230)              64

5.10.2      EXPORT DATA (HS CODE 842230)              65

5.11         KEY CONFERENCES AND EVENTS, 2025–2026        66

5.12         CASE STUDIES  67

5.12.1      ZAMBON COMPANY S.P.A. AND IMA ACTIVE COLLABORATED ON PROCESS OPTIMIZATION PROJECT TO ENHANCE BATCH CONSISTENCY AND QUALITY               67

5.12.2      ACG HELPED INDIAN PHARMACEUTICAL COMPANY RETROFIT B MAX MACHINE WITH NITROGEN-ENHANCED PURGING SYSTEM           68

5.12.3      SYNTEGON PROVIDED JIANGSU WITH AIM 5022S PLATFORM TO ENHANCE INSPECTION EFFICIENCY AND ACCURACY          68

5.13         REGULATIONS LANDSCAPE        69

5.13.1      REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             69

5.13.2      STANDARDS      71

5.14         PORTER’S FIVE FORCES ANALYSIS            72

5.14.1      BARGAINING POWER OF SUPPLIERS       73

5.14.2      BARGAINING POWER OF BUYERS             73

5.14.3      THREAT OF NEW ENTRANTS      73

5.14.4      THREAT OF SUBSTITUTES          73

5.14.5      INTENSITY OF COMPETITIVE RIVALRY 74

5.15         KEY STAKEHOLDERS AND BUYING CRITERIA     74

5.15.1      KEY STAKEHOLDERS IN BUYING PROCESS           74

5.15.2      BUYING CRITERIA           75

6               PHARMACEUTICAL MANUFACTURING EQUIPMENT SUPPLIERS AND AFTERMARKET SUPPLIERS        76

6.1           INTRODUCTION              76

6.2           ORIGINAL EQUIPMENT MANUFACTURERS          76

6.3           AFTERMARKET SUPPLIERS          77

7               MAJOR PHARMACEUTICAL EQUIPMENT MANUFACTURING PROCESSES 78

7.1           INTRODUCTION              78

7.2           FORMULATION PROCESS             79

7.3           TABLETING AND ENCAPSULATION PROCESS    79

7.4           ASEPTIC PROCESS           80

7.5           PACKAGING PROCESS   80

7.6           QUALITY CONTROL PROCESS   80

8               END USERS OF PHARMACEUTICAL MANUFACTURING EQUIPMENT      82

8.1           INTRODUCTION              82

8.2           PHARMACEUTICAL MANUFACTURING COMPANIES                 82

8.3           CONTRACT MANUFACTURING ORGANIZATIONS                 83

9               PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,

BY END-PRODUCT TYPE               84

9.1           INTRODUCTION              85

9.2           SOLID   86

9.2.1        ONGOING TECHNOLOGICAL INNOVATIONS TO DRIVE MARKET               86

9.3           LIQUID 88

9.3.1        RISING APPLICATION FOR UNSTABLE DRUGS IN SOLID FORM

TO BOOST DEMAND      88

10            PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE 90

10.1         INTRODUCTION              91

10.2         PACKAGING MACHINES                93

10.2.1      RISING NEED TO ENSURE PROTECTION AGAINST DAMAGE AND CONTAMINATION TO FUEL MARKET GROWTH                 93

10.3         FILLING MACHINES        97

10.3.1      GROWING NEED FOR COMPLIANCE WITH STRINGENT REGULATORY STANDARDS TO FOSTER MARKET GROWTH                 97

10.4         SPRAY DRYING EQUIPMENT      101

10.4.1      PRESSING NEED TO PRODUCE HIGH-QUALITY DRUG PRODUCTS TO FUEL MARKET GROWTH               101

10.5         MIXING AND BLENDING MACHINES       104

10.5.1      ABILITY TO PROVIDE CONTROLLED AND CONSISTENT AGITATION AND SHEAR FORCES TO ENSURE HOMOGENEITY OF DRUG FORMULATION TO BOOST DEMAND 104

10.6         MILLING EQUIPMENT   108

10.6.1      RISING NEED TO REDUCE PARTICLE SIZE OF DRUG FORMULATIONS TO FOSTER MARKET GROWTH               108

10.7         EXTRUSION EQUIPMENT             112

10.7.1      ELEVATING USE TO PRODUCE VARIOUS DOSAGE FORMS TO FUEL MARKET GROWTH       112

10.8         TABLET COMPRESSION PRESSES              115

10.8.1      INCREASING PREFERENCE FOR SOLID DOSAGE FORMS TO DRIVE MARKET         115

10.9         INSPECTION EQUIPMENT           119

10.9.1      SURGING NEED TO ENSURE QUALITY AND INTEGRITY OF DRUG PRODUCTS TO FOSTER MARKET GROWTH    119

10.10       GRANULATION EQUIPMENT      123

10.10.1   ABILITY TO IMPROVE OVERALL STABILITY AND BIOAVAILABILITY OF DRUGS TO BOOST DEMAND          123

10.11       STERILIZATION EQUIPMENT     126

10.11.1   GROWING DEMAND FOR CONTAMINATION-FREE DRUGS AND PRODUCTS TO DRIVE MARKET       126

11            PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION     130

11.1         INTRODUCTION              131

11.2         NORTH AMERICA             133

11.2.1      MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 133

11.2.2      US           136

11.2.2.1  Government-led initiatives to advance pharmaceutical manufacturing capacity to drive market            136

11.2.3      CANADA               138

11.2.3.1  Rising emphasis on strengthening domestic manufacturing capabilities to foster market growth  138

11.2.4      MEXICO                139

11.2.4.1  Increasing focus on streamlining pharmaceutical regulatory processes to fuel market growth         139

11.3         EUROPE               141

11.3.1      MACROECONOMIC OUTLOOK FOR EUROPE      141

11.3.2      UK          143

11.3.2.1  Rising emphasis on developing advanced manufacturing equipment to offer lucrative growth opportunities          143

11.3.3      GERMANY           145

11.3.3.1  Escalating demand for branded and generic drugs to foster market growth       145

11.3.4      FRANCE                146

11.3.4.1  Government-led policies to encourage investment and innovation in pharmaceutical manufacturing industry to accelerate demand  146

11.3.5      ITALY    148

11.3.5.1  Growing focus on establishing pharmaceutical manufacturing facilities to create significant growth opportunities        148

11.3.6      REST OF EUROPE             149

11.4         ASIA PACIFIC     151

11.4.1      MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 151

11.4.2      CHINA  154

11.4.2.1  Surging FDIs and regulatory reforms to streamline drug approvals to offer lucrative growth opportunities            154

11.4.3      JAPAN   156

11.4.3.1  Increasing demand for innovative pharmaceutical manufacturing solutions to fuel market growth          156

11.4.4      INDIA    157

11.4.4.1  Government-led initiatives to strengthen domestic manufacturing to boost demand        157

11.4.5      SOUTH KOREA  159

11.4.5.1  Low import tariffs and enhanced regulatory transparency to attract foreign investments to foster market growth       159

11.4.6      REST OF ASIA PACIFIC   160

11.5         ROW      161

11.5.1      MACROECONOMIC OUTLOOK FOR ROW              161

11.5.2      MIDDLE EAST   164

11.5.2.1  Expanding pharmaceutical manufacturing infrastructure to offer growth opportunities            164

11.5.2.2  GCC       164

11.5.2.3  Rest of Middle East              164

11.5.3      AFRICA 166

11.5.3.1  Rising investment in local pharmaceutical manufacturing to fuel market growth       166

11.5.4      SOUTH AMERICA             166

11.5.4.1  Introduction of tax incentives to strengthen pharmaceutical manufacturing to support market growth         166

12            COMPETITIVE LANDSCAPE         167

12.1         OVERVIEW          167

12.2         KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022–2024                 167

12.3         REVENUE ANALYSIS, 2019–2023  169

12.4         MARKET SHARE ANALYSIS, 2023                 169

12.5         COMPANY VALUATION AND FINANCIAL METRICS, 2024                 172

12.6         BRAND/PRODUCT COMPARISON             174

12.7         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023                 175

12.7.1      STARS   175

12.7.2      EMERGING LEADERS     175

12.7.3      PERVASIVE PLAYERS      175

12.7.4      PARTICIPANTS 175

12.7.5      COMPANY FOOTPRINT: KEY PLAYERS, 2023         177

12.7.5.1  Company footprint               177

12.7.5.2  Region footprint   178

12.7.5.3  Primary packaging equipment footprint           179

12.7.5.4  Secondary packaging equipment footprint       180

12.7.5.5  Type footprint       181

12.8         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023        182

12.8.1      PROGRESSIVE COMPANIES         182

12.8.2      RESPONSIVE COMPANIES            182

12.8.3      DYNAMIC COMPANIES  182

12.8.4      STARTING BLOCKS         182

12.8.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023                 184

12.8.5.1  Detailed list of key startups/SMEs    184

12.8.5.2  Competitive benchmarking of key startups/SMEs          184

12.9         COMPETITIVE SCENARIO             185

12.9.1      PRODUCT LAUNCHES   185

12.9.2      DEALS  186

13            COMPANY PROFILES      187

13.1         KEY PLAYERS     187

13.1.1      GEA GROUP AKTIENGESELLSCHAFT      187

13.1.1.1  Business overview 187

13.1.1.2  Products/Solutions/Services offered 189

13.1.1.3  Recent developments           190

13.1.1.3.1                Product launches  190

13.1.1.3.2                Deals      190

13.1.1.4  MnM view              191

13.1.1.4.1                Key strengths/Right to win 191

13.1.1.4.2                Strategic choices   191

13.1.1.4.3                Weaknesses/Competitive threats       191

13.1.2      I.M.A INDUSTRIA MACCHINE AUTOMATICHE S.P.A.                 192

13.1.2.1  Business overview 192

13.1.2.2  Products/Solutions/Services offered 193

13.1.2.3  Recent developments           194

13.1.2.3.1                Deals      194

13.1.2.4  MnM view              194

13.1.2.4.1                Key strengths/Right to win 194

13.1.2.4.2                Strategic choices   195

13.1.2.4.3                Weaknesses/Competitive threats       195

13.1.3      SYNTEGON TECHNOLOGY GMBH            196

13.1.3.1  Business overview 196

13.1.3.2  Products/Solutions/Services offered 197

13.1.3.3  Recent developments           197

13.1.3.3.1                Product launches  197

13.1.3.3.2                Deals      198

13.1.3.3.3                Expansions             199

13.1.3.4  MnM view              199

13.1.3.4.1                Key strengths/Right to win 199

13.1.3.4.2                Strategic choices   199

13.1.3.4.3                Weaknesses/Competitive threats       199

13.1.4      ACG       200

13.1.4.1  Business overview 200

13.1.4.2  Products/Solutions/Services offered 200

13.1.4.3  Recent developments           201

13.1.4.3.1                Deals      201

13.1.4.3.2                Expansions             202

13.1.4.4  MnM view              202

13.1.4.4.1                Key strengths/Right to win 202

13.1.4.4.2                Strategic choices   202

13.1.4.4.3                Weaknesses/Competitive threats       202

13.1.5      THERMO FISHER SCIENTIFIC INC.            203

13.1.5.1  Business overview 203

13.1.5.2  Products/Solutions/Services offered 205

13.1.5.3  Recent developments           205

13.1.5.3.1                Deals      205

13.1.5.3.2                Expansions             206

13.1.5.4  MnM view              207

13.1.5.4.1                Key strengths/Right to win 207

13.1.5.4.2                Strategic choices   207

13.1.5.4.3                Weaknesses/Competitive threats       207

13.1.6      ROMACO GROUP             208

13.1.6.1  Business overview 208

13.1.6.2  Products/Solutions/Services offered 209

13.1.6.3  Recent developments           210

13.1.6.3.1                Product launches  210

13.1.6.3.2                Deals      210

13.1.7      KÖRBER AG        211

13.1.7.1  Business overview 211

13.1.7.2  Products/Solutions/Services offered 212

13.1.7.3  Recent developments           213

13.1.7.3.1                Deals      213

13.1.7.3.2                Expansions             214

13.1.8      MARCHESINI GROUP S.P.A.         215

13.1.8.1  Business overview 215

13.1.8.2  Products/Solutions/Services offered 215

13.1.8.3  Recent developments           216

13.1.8.3.1                Product launches  216

13.1.8.3.2                Deals      217

13.1.9      MG2 S.R.L.           218

13.1.9.1  Business overview 218

13.1.9.2  Products/Solutions/Services offered 218

13.1.9.3  Recent developments           220

13.1.9.3.1                Product launches  220

13.1.10   GLATT GMBH    221

13.1.10.1                 Business overview 221

13.1.10.2                 Products/Solutions/Services offered 221

13.2         OTHER PLAYERS              222

13.2.1      BAUSCH+STRÖBEL SE + CO. KG                222

13.2.2      COPERION GMBH            223

13.2.3      ELIZABETH COMPANIES               224

13.2.4      FETTE COMPACTING    225

13.2.5      FREUND               226

13.2.6      KORSCH AG        227

13.2.7      L.B. BOHLE MASCHINEN UND VERFAHREN GMBH                 228

13.2.8      LFA MACHINES 229

13.2.9      CVC TECHNOLOGIES, INC.          230

13.2.10   OHARA TECHNOLOGIES               231

13.2.11   PRISM PHARMA MACHINERY      232

13.2.12   SAINTYCO           233

13.2.13   SILVERSON         234

13.2.14   YENCHEN MACHINERY CO., LTD              234

13.2.15   QUALICAPS        235

13.2.16   COESIA S.P.A.     236

13.2.17   UHLMANN          237

13.2.18   AUTOMATED SYSTEMS OF TACOMA, LLC             238

14            APPENDIX           239

14.1         INSIGHTS FROM INDUSTRY EXPERTS     239

14.2         DISCUSSION GUIDE        240

14.3         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                243

14.4         CUSTOMIZATION OPTIONS        245

14.5         RELATED REPORTS         245

14.6         AUTHOR DETAILS           246

LIST OF TABLES

TABLE 1                PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: RISK ANALYSIS   40

TABLE 2                INDICATIVE PRICING OF PHARMACEUTICAL MANUFACTURING EQUIPMENT OFFERED BY KEY PLAYERS, BY EQUIPMENT TYPE, 2023 (USD)  53

TABLE 3                AVERAGE SELLING PRICE TREND OF PHARMACEUTICAL PACKAGING MACHINES, 2019–2023 (USD)                 54

TABLE 4                AVERAGE SELLING PRICE TREND OF PHARMACEUTICAL PACKAGING MACHINES,

BY REGION, 2019–2023 (USD)      55

TABLE 5                ROLES OF COMPANIES IN PHARMACEUTICAL MANUFACTURING

EQUIPMENT ECOSYSTEM            58

TABLE 6                LIST OF MAJOR PATENTS             63

TABLE 7                IMPORT DATA FOR HS CODE 842230-COMPLIANT PRODUCTS, BY COUNTRY, 2019–2023 (USD MILLION)            65

TABLE 8                EXPORT DATA FOR HS CODE 842230-COMPLIANT PRODUCTS, BY COUNTRY, 2019–2023 (USD MILLION)            66

TABLE 9                LIST OF KEY CONFERENCES AND EVENTS, 2025–2026        66

TABLE 10              NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  69

TABLE 11              EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  70

TABLE 12              ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  70

TABLE 13              ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  71

TABLE 14              STANDARDS PERTAINING TO PHARMACEUTICAL MANUFACTURING EQUIPMENT       71

TABLE 15              PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: PORTER’S FIVE FORCES ANALYSIS                 72

TABLE 16              INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END-PRODUCT TYPES     74

TABLE 17              KEY BUYING CRITERIA FOR END-PRODUCT TYPES   75

TABLE 18              PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,

BY END-PRODUCT TYPE, 2020–2023 (USD MILLION)        86

TABLE 19              PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,

BY END-PRODUCT TYPE, 2024–2029 (USD MILLION)        86

TABLE 20              SOLID: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2020–2023 (USD MILLION)            87

TABLE 21              SOLID: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2024–2029 (USD MILLION)            87

TABLE 22              LIQUID: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,

BY EQUIPMENT TYPE, 2020–2023 (USD MILLION)              88

TABLE 23              LIQUID: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,

BY EQUIPMENT TYPE, 2024–2029 (USD MILLION)              89

TABLE 24              PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2020–2023 (THOUSAND UNITS)      92

TABLE 25              PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2024–2029 (THOUSAND UNITS)      92

TABLE 26              PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2020–2023 (USD MILLION)            92

TABLE 27              PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2024–2029 (USD MILLION)            93

TABLE 28              PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2020–2023 (USD MILLION)                94

TABLE 29              PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2024–2029 (USD MILLION)                94

TABLE 30              PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2020–2023 (USD MILLION) 94

TABLE 31              PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2024–2029 (USD MILLION) 94

TABLE 32              PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2020–2023 (USD MILLION)               95

TABLE 33              PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2024–2029 (USD MILLION)               95

TABLE 34              PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2020–2023 (USD MILLION)     95

TABLE 35              PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2024–2029 (USD MILLION)     96

TABLE 36              PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2020–2023 (USD MILLION)     96

TABLE 37              PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2024–2029 (USD MILLION)     96

TABLE 38              FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,

BY END-PRODUCT TYPE, 2020–2023 (USD MILLION)        97

TABLE 39              FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,

BY END-PRODUCT TYPE, 2024–2029 (USD MILLION)        98

TABLE 40              FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,

BY REGION, 2020–2023 (USD MILLION)   98

TABLE 41              FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,

BY REGION, 2024–2029 (USD MILLION)   98

TABLE 42              FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET

IN NORTH AMERICA, BY COUNTRY, 2020–2023 (USD MILLION)                 99

TABLE 43              FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET

IN NORTH AMERICA, BY COUNTRY, 2024–2029 (USD MILLION)                 99

TABLE 44              FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET

IN EUROPE, BY COUNTRY, 2020–2023 (USD MILLION)      99

TABLE 45              FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET

IN EUROPE, BY COUNTRY, 2024–2029 (USD MILLION)      100

TABLE 46              FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET

IN ASIA PACIFIC, BY COUNTRY, 2020–2023 (USD MILLION)                 100

TABLE 47              FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET

IN ASIA PACIFIC, BY COUNTRY, 2024–2029 (USD MILLION)                 100

TABLE 48              SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2020–2023 (USD MILLION)        101

TABLE 49              SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2024–2029 (USD MILLION)        101

TABLE 50              SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2020–2023 (USD MILLION)   102

TABLE 51              SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2024–2029 (USD MILLION)   102

TABLE 52              SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2020–2023 (USD MILLION)                 102

TABLE 53              SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2024–2029 (USD MILLION)                 103

TABLE 54              SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2020–2023 (USD MILLION)            103

TABLE 55              SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2024–2029 (USD MILLION)            103

TABLE 56              SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2020–2023 (USD MILLION) 104

TABLE 57              SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2024–2029 (USD MILLION) 104

TABLE 58              MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2020–2023 (USD MILLION)        105

TABLE 59              MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2024–2029 (USD MILLION)        105

TABLE 60              MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2020–2023 (USD MILLION)   105

TABLE 61              MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2024–2029 (USD MILLION)   106

TABLE 62              MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY,

2020–2023 (USD MILLION)            106

TABLE 63              MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY,

2024–2029 (USD MILLION)            106

TABLE 64              MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2020–2023 (USD MILLION)            107

TABLE 65              MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2024–2029 (USD MILLION)            107

TABLE 66              MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2020–2023 (USD MILLION) 107

TABLE 67              MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2024–2029 (USD MILLION) 108

TABLE 68              MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2020–2023 (USD MILLION)                108

TABLE 69              MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2024–2029 (USD MILLION)                109

TABLE 70              MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2020–2023 (USD MILLION) 109

TABLE 71              MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2024–2029 (USD MILLION) 109

TABLE 72              MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2020–2023 (USD MILLION)               110

TABLE 73              MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2024–2029 (USD MILLION)               110

TABLE 74              MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2020–2023 (USD MILLION)     110

TABLE 75              MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2024–2029 (USD MILLION)     111

TABLE 76              MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2020–2023 (USD MILLION)     111

TABLE 77              MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2024–2029 (USD MILLION)     111

TABLE 78              EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2020–2023 (USD MILLION)                112

TABLE 79              EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2024–2029 (USD MILLION)                112

TABLE 80              EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2020–2023 (USD MILLION) 113

TABLE 81              EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2024–2029 (USD MILLION) 113

TABLE 82              EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2020–2023 (USD MILLION)               113

TABLE 83              EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2024–2029 (USD MILLION)               114

TABLE 84              EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2020–2023 (USD MILLION)     114

TABLE 85              EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2024–2029 (USD MILLION)     114

TABLE 86              EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2020–2023 (USD MILLION)     115

TABLE 87              EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2024–2029 (USD MILLION)     115

TABLE 88              TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2020–2023 (USD MILLION)        116

TABLE 89              TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2024–2029 (USD MILLION)        116

TABLE 90              TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2020–2023 (USD MILLION)   116

TABLE 91              TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2024–2029 (USD MILLION)   117

TABLE 92              TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY,

2020–2023 (USD MILLION)            117

TABLE 93              TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY,

2024–2029 (USD MILLION)            117

TABLE 94              TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2020–2023 (USD MILLION)            118

TABLE 95              TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2024–2029 (USD MILLION)            118

TABLE 96              TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2020–2023 (USD MILLION) 118

TABLE 97              TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2024–2029 (USD MILLION) 119

TABLE 98              INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2020–2023 (USD MILLION)                120

TABLE 99              INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2024–2029 (USD MILLION)                120

TABLE 100            INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2020–2023 (USD MILLION) 120

TABLE 101            INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2024–2029 (USD MILLION) 120

TABLE 102            INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2020–2023 (USD MILLION)               121

TABLE 103            INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2024–2029 (USD MILLION)               121

TABLE 104            INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2020–2023 (USD MILLION)     121

TABLE 105            INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2024–2029 (USD MILLION)     122

TABLE 106            INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2020–2023 (USD MILLION)     122

TABLE 107            INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2024–2029 (USD MILLION)     122

TABLE 108            GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2020–2023 (USD MILLION)        123

TABLE 109            GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2024–2029 (USD MILLION)        123

TABLE 110            GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2020–2023 (USD MILLION)   124

TABLE 111            GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2024–2029 (USD MILLION)   124

TABLE 112            GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2020–2023 (USD MILLION)                 124

TABLE 113            GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2024–2029 (USD MILLION)                 124

TABLE 114            GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2020–2023 (USD MILLION)            125

TABLE 115            GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2024–2029 (USD MILLION)            125

TABLE 116            GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2020–2023 (USD MILLION) 125

TABLE 117            GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2024–2029 (USD MILLION) 126

TABLE 118            STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2020–2023 (USD MILLION)        126

TABLE 119            STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2024–2029 (USD MILLION)        127

TABLE 120            STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2020–2023 (USD MILLION)   127

TABLE 121            STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2024–2029 (USD MILLION)   127

TABLE 122            STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2020–2023 (USD MILLION)                 127

TABLE 123            STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2024–2029 (USD MILLION)                 128

TABLE 124            STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2020–2023 (USD MILLION)            128

TABLE 125            STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2024–2029 (USD MILLION)            128

TABLE 126            STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2020–2023 (USD MILLION) 129

TABLE 127            STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2024–2029 (USD MILLION) 129

TABLE 128            PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION,

2020–2023 (USD MILLION)            132

TABLE 129            PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION,

2024–2029 (USD MILLION)            132

TABLE 130            NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,

BY COUNTRY, 2020–2023 (USD MILLION)               134

TABLE 131            NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,

BY COUNTRY, 2024–2029 (USD MILLION)               135

TABLE 132            NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,

BY EQUIPMENT TYPE, 2020–2023 (USD MILLION)              135

TABLE 133            NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,

BY EQUIPMENT TYPE, 2024–2029 (USD MILLION)              136

TABLE 134            US: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2020–2023 (USD MILLION)            137

TABLE 135            US: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2024–2029 (USD MILLION)            137

TABLE 136            CANADA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,

BY EQUIPMENT TYPE, 2020–2023 (USD MILLION)              138

TABLE 137            CANADA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,

BY EQUIPMENT TYPE, 2024–2029 (USD MILLION)              139

TABLE 138            MEXICO: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,

BY EQUIPMENT TYPE, 2020–2023 (USD MILLION)              140

TABLE 139            MEXICO: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,

BY EQUIPMENT TYPE, 2024–2029 (USD MILLION)              140

TABLE 140            EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,

BY COUNTRY, 2020–2023 (USD MILLION)               143

TABLE 141            EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,

BY COUNTRY, 2024–2029 (USD MILLION)               143

TABLE 142            UK: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2020–2023 (USD MILLION)            144

TABLE 143            UK: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2024–2029 (USD MILLION)            144

TABLE 144            GERMANY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,

BY EQUIPMENT TYPE, 2020–2023 (USD MILLION)              145

TABLE 145            GERMANY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,

BY EQUIPMENT TYPE, 2024–2029 (USD MILLION)              146

TABLE 146            FRANCE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,

BY EQUIPMENT TYPE, 2020–2023 (USD MILLION)              147

TABLE 147            FRANCE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,

BY EQUIPMENT TYPE, 2024–2029 (USD MILLION)              147

TABLE 148            ITALY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2020–2023 (USD MILLION)            148

TABLE 149            ITALY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2024–2029 (USD MILLION)            149

TABLE 150            REST OF EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,

BY EQUIPMENT TYPE, 2020–2023 (USD MILLION)            150

TABLE 151            REST OF EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,

BY EQUIPMENT TYPE, 2024–2029 (USD MILLION)              150

TABLE 152            ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,

BY COUNTRY, 2020–2023 (USD MILLION)               153

TABLE 153            ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,

BY COUNTRY, 2024–2029 (USD MILLION)             153

TABLE 154            ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,

BY EQUIPMENT TYPE, 2020–2023 (USD MILLION)            153

TABLE 155            ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,

BY EQUIPMENT TYPE, 2024–2029 (USD MILLION)              154

TABLE 156            CHINA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2020–2023 (USD MILLION)            155

TABLE 157            CHINA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2024–2029 (USD MILLION)            155

TABLE 158            JAPAN: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2020–2023 (USD MILLION)            156

TABLE 159            JAPAN: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2024–2029 (USD MILLION)            157

TABLE 160            INDIA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2020–2023 (USD MILLION)            158

TABLE 161            INDIA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2024–2029 (USD MILLION)            158

TABLE 162            SOUTH KOREA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,

BY EQUIPMENT TYPE, 2020–2023 (USD MILLION)              159

TABLE 163            SOUTH KOREA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,

BY EQUIPMENT TYPE, 2024–2029 (USD MILLION)              160

TABLE 164            REST OF ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2020–2023 (USD MILLION)            160

TABLE 165            REST OF ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2024–2029 (USD MILLION)            161

TABLE 166            ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2020–2023 (USD MILLION)                 162

TABLE 167            ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2024–2029 (USD MILLION)                 162

TABLE 168            ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2020–2023 (USD MILLION)            163

TABLE 169            ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2024–2029 (USD MILLION)            163

TABLE 170            MIDDLE EAST: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,

BY COUNTRY, 2020–2023 (USD MILLION)               165

TABLE 171            MIDDLE EAST: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,

BY COUNTRY, 2024–2029 (USD MILLION)               165

TABLE 172            OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS, 2022–2024         167

TABLE 173            PHARMACEUTICAL PACKAGING MACHINES MARKET:

DEGREE OF COMPETITION, 2023               170

TABLE 174            PHARMACEUTICAL PACKAGING MACHINES MARKET: REGION FOOTPRINT 178

TABLE 175            PHARMACEUTICAL PACKAGING MACHINES MARKET: PRIMARY PACKAGING EQUIPMENT FOOTPRINT                 179

TABLE 176            PHARMACEUTICAL PACKAGING MACHINES MARKET: SECONDARY PACKAGING EQUIPMENT FOOTPRINT                 180

TABLE 177            PHARMACEUTICAL PACKAGING MACHINES MARKET: TYPE FOOTPRINT       181

TABLE 178            PHARMACEUTICAL PACKAGING MACHINES MARKET: DETAILED LIST

OF KEY STARTUPS/SMES              184

TABLE 179            PHARMACEUTICAL PACKAGING MACHINES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES              184

TABLE 180            PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET:

PRODUCT LAUNCHES, JANUARY 2022–OCTOBER 2024    185

TABLE 181            PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET:

DEALS, JANUARY 2022–OCTOBER 2024    186

TABLE 182            GEA GROUP AKTIENGESELLSCHAFT: COMPANY OVERVIEW          187

TABLE 183            GEA GROUP AKTIENGESELLSCHAFT: PRODUCTS/SOLUTIONS/SERVICES OFFERED    189

TABLE 184            GEA GROUP AKTIENGESELLSCHAFT: PRODUCT LAUNCHES          190

TABLE 185            GEA GROUP AKTIENGESELLSCHAFT: DEALS                 190

TABLE 186            I.M.A INDUSTRIA MACCHINE AUTOMATICHE S.P.A.: COMPANY OVERVIEW      192

TABLE 187            I.M.A INDUSTRIA MACCHINE AUTOMATICHE S.P.A.: PRODUCT/SOLUTIONS/SERVICES OFFERED         193

TABLE 188            I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P.A.: DEALS     194

TABLE 189            SYNTEGON TECHNOLOGY GMBH: COMPANY OVERVIEW          196

TABLE 190            SYNTEGON TECHNOLOGY GMBH: PRODUCTS/SOLUTIONS/SERVICES OFFERED    197

TABLE 191            SYNTEGON TECHNOLOGY GMBH: PRODUCT LAUNCHES          197

TABLE 192            SYNTEGON TECHNOLOGY GMBH: DEALS                 198

TABLE 193            SYNTEGON TECHNOLOGY GMBH: EXPANSIONS                 199

TABLE 194            ACG: COMPANY OVERVIEW        200

TABLE 195            ACG: PRODUCTS/SOLUTIONS/SERVICES OFFERED             200

TABLE 196            ACG: DEALS       201

TABLE 197            ACG: EXPANSIONS          202

TABLE 198            THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW          203

TABLE 199            THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED    205

TABLE 200            THERMO FISHER SCIENTIFIC INC.: DEALS                 205

TABLE 201            THERMO FISHER SCIENTIFIC INC.: EXPANSIONS                 206

TABLE 202            ROMACO GROUP: COMPANY OVERVIEW                 208

TABLE 203            ROMACO GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED    209

TABLE 204            ROMACO GROUP: PRODUCT LAUNCHES                 210

TABLE 205            ROMACO GROUP: DEALS             210

TABLE 206            KÖRBER AG: COMPANY OVERVIEW         211

TABLE 207            KÖRBER AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED             212

TABLE 208            KÖRBER AG: DEALS        213

TABLE 209            KÖRBER AG: EXPANSIONS           214

TABLE 210            MARCHESINI GROUP S.P.A.: COMPANY OVERVIEW          215

TABLE 211            MARCHESINI GROUP S.P.A.: PRODUCTS/SOLUTIONS/SERVICES OFFERED    215

TABLE 212            MARCHESINI GROUP S.P.A.: PRODUCT LAUNCHES          216

TABLE 213            MARCHESINI GROUP S.P.A.: DEALS          217

TABLE 214            MG2 S.R.L.: COMPANY OVERVIEW            218

TABLE 215            MG2 S.R.L.: PRODUCTS/SOLUTIONS/SERVICES OFFERED             218

TABLE 216            MG2 S.R.L.: PRODUCT LAUNCHES            220

TABLE 217            GLATT GMBH: COMPANY OVERVIEW    221

TABLE 218            GLATT GMBH: PRODUCTS/SOLUTIONS/SERVICES OFFERED    221

TABLE 219            BAUSCH+STRÖBEL SE + CO. KG: COMPANY OVERVIEW          222

TABLE 220            COPERION GMBH: COMPANY OVERVIEW                 223

TABLE 221            ELIZABETH COMPANIES: COMPANY OVERVIEW                 224

TABLE 222            FETTE COMPACTING: COMPANY OVERVIEW                 225

TABLE 223            FREUND: COMPANY OVERVIEW                226

TABLE 224            KORSCH AG: COMPANY OVERVIEW        227

TABLE 225            L.B. BOHLE MASCHINEN UND VERFAHREN GMBH: COMPANY OVERVIEW    228

TABLE 226            LFA MACHINES: COMPANY OVERVIEW  229

TABLE 227            CVC TECHNOLOGIES, INC.: COMPANY OVERVIEW          230

TABLE 228            OHARA TECHNOLOGIES: COMPANY OVERVIEW                 231

TABLE 229            PRISM PHARMA MACHINERY: COMPANY OVERVIEW          232

TABLE 230            SAINTYCO: COMPANY OVERVIEW            233

TABLE 231            SILVERSON: COMPANY OVERVIEW          234

TABLE 232            YENCHEN MACHINERY CO., LTD: COMPANY OVERVIEW          234

TABLE 233            QUALICAPS: COMPANY OVERVIEW         235

TABLE 234            COESIA S.P.A.: COMPANY OVERVIEW     236

TABLE 235            UHLMANN: COMPANY OVERVIEW           237

TABLE 236            AUTOMATED SYSTEMS OF TACOMA, LLC: COMPANY OVERVIEW   238

LIST OF FIGURES

FIGURE 1              PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SEGMENTATION 27

FIGURE 2              PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: RESEARCH DESIGN          30

FIGURE 3              MARKET SIZE ESTIMATION METHODOLOGY (SUPPLY SIDE): REVENUE GENERATED FROM PHARMACEUTICAL PACKAGING MACHINES       35

FIGURE 4              PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET:

BOTTOM-UP APPROACH              36

FIGURE 5              PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: TOP-DOWN APPROACH 37

FIGURE 6              PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: DATA TRIANGULATION 38

FIGURE 7              PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET:

RESEARCH ASSUMPTIONS           39

FIGURE 8              PACKAGING MACHINES TO HOLD DOMINANT MARKET SHARE IN 2029 42

FIGURE 9              SOLID SEGMENT TO CLAIM LARGEST MARKET SHARE IN 2024   42

FIGURE 10            ASIA PACIFIC DOMINATED MARKET IN 2023                 43

FIGURE 11            GROWING DEMAND FOR FLEXIBLE PHARMACEUTICAL MANUFACTURING TO OFFER LUCRATIVE GROWTH OPPORTUNITIES         44

FIGURE 12            PACKAGING MACHINES TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD          45

FIGURE 13            LIQUID SEGMENT TO EXHIBIT HIGHER CAGR DURING FORECAST PERIOD       45

FIGURE 14            INDIA TO REGISTER HIGHEST CAGR IN GLOBAL MARKET DURING

FORECAST PERIOD         46

FIGURE 15            PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES          47

FIGURE 16            PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET:

IMPACT ANALYSIS OF DRIVERS 49

FIGURE 17            PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET:

IMPACT ANALYSIS OF RESTRAINTS         50

FIGURE 18            PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET:

IMPACT ANALYSIS OF OPPORTUNITIES                51

FIGURE 19            PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET:

IMPACT ANALYSIS OF CHALLENGES       52

FIGURE 20            TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS   52

FIGURE 21            AVERAGE SELLING PRICE TREND OF PHARMACEUTICAL PACKAGING MACHINES, 2019–2023  54

FIGURE 22            AVERAGE SELLING PRICE TREND OF PHARMACEUTICAL PACKAGING MACHINES,

BY REGION, 2019–2023    55

FIGURE 23            VALUE CHAIN ANALYSIS               56

FIGURE 24            PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET ECOSYSTEM ANALYSIS    58

FIGURE 25            IMPACT OF AI/GENERATIVE AI ON PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET                 59

FIGURE 26            PATENTS APPLIED AND GRANTED, 2014–2023                 62

FIGURE 27            IMPORT DATA FOR HS CODE 842230-COMPLIANT PRODUCTS, BY COUNTRY, 2019–2023            64

FIGURE 28            EXPORT DATA FOR HS CODE 842230-COMPLIANT PRODUCTS, BY COUNTRY, 2019–2023            65

FIGURE 29            PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: PORTER’S FIVE FORCES ANALYSIS                 72

FIGURE 30            INFLUENCE OF STAKEHOLDERS IN PHARMACEUTICAL MANUFACTURING EQUIPMENT FOR END-PRODUCT TYPE                74

FIGURE 31            KEY BUYING CRITERIA FOR PHARMACEUTICAL MANUFACTURING EQUIPMENT FOR END-PRODUCT TYPES                 75

FIGURE 32            SOLID SEGMENT TO HOLD LARGER MARKET SHARE IN 2024   85

FIGURE 33            PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE     91

FIGURE 34            PACKAGING MACHINES TO RECORD HIGHEST CAGR DURING FORECAST PERIOD          91

FIGURE 35            PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION           131

FIGURE 36            ASIA PACIFIC TO ACCOUNT FOR LARGEST MARKET SHARE IN 2024 132

FIGURE 37            NORTH AMERICA: PHARMACEUTICAL MANUFACTURING

EQUIPMENT MARKET SNAPSHOT            134

FIGURE 38            EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SNAPSHOT     142

FIGURE 39            ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SNAPSHOT     152

FIGURE 40            SOUTH AMERICA TO DOMINATE MARKET IN ROW REGION IN 2024     162

FIGURE 41            PHARMACEUTICAL PACKAGING MACHINES MARKET: REVENUE ANALYSIS

OF KEY PLAYERS, 2019–2023         169

FIGURE 42            MARKET SHARE ANALYSIS OF KEY PLAYERS OFFERING PHARMACEUTICAL PACKAGING MACHINES, 2023                 170

FIGURE 43            PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET:

COMPANY VALUATION, 2024      172

FIGURE 44            PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: FINANCIAL METRICS (EV/EBITDA), 2024                 173

FIGURE 45            PHARMACEUTICAL PACKAGING MACHINES MARKET: BRAND/PRODUCT COMPARISON         174

FIGURE 46            PHARMACEUTICAL PACKAGING MACHINES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023                 176

FIGURE 47            PHARMACEUTICAL PACKAGING MACHINES MARKET: COMPANY FOOTPRINT             177

FIGURE 48            PHARMACEUTICAL PACKAGING MACHINES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023        183

FIGURE 49            GEA GROUP AKTIENGESELLSCHAFT: COMPANY SNAPSHOT          188

FIGURE 50            THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT          204

FIGURE 51            KÖRBER AG: COMPANY SNAPSHOT         212

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧